Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02857270
Title	A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Eli Lilly and Company
Indications	pancreatic ductal adenocarcinoma Advanced Solid Tumor melanoma colorectal cancer lung non-small cell carcinoma
Therapies	LY3214996 Gemcitabine + LY3214996 + Nab-paclitaxel LY3214996 + Midazolam Abemaciclib + LY3214996
Age Groups:	adult \| senior
Covered Countries	USA \| FRA \| AUS